Raltegravir and Maraviroc in Combination for the Treatment of Antiretroviral Naive HIV-1 Infected Patients.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Raltegravir (Primary) ; Maraviroc
- Indications HIV-1 infections
- Focus Therapeutic Use
- 08 Nov 2012 Planned End Date changed from 1 Sep 2012 to 1 Sep 2014 according to ClinicalTrials.gov record.
- 25 Sep 2010 New trial record